The Pharmaceutical Journal
Vol 280 pp293-322 No 7493
15 March 2008

The Pharmaceutical Journal, 15 March 2008

OTHER ISSUES
Previous   Next   Back issues

PJ Online home  |  Search PJ Online

 Acrobat Reader

List of Contents

Leading articles
News
News feature

COMMENT
Broad spectrum
Letters


Articles

Footler (topical observations)

My career

THE SOCIETY
Official notices
Deaths and tributes
Branch/Society meetings


JOURNAL NOTICE-BOARD   PDF (40K)
Products
Announcements
Medical device alert (Smiths Medical cassette reservoirs for CADD pumps)
Resources
Future events

Bogus calls
Market researchers, masquerading as employees of The Pharmaceutical Journal, have again been telephoning pharmacists asking for personal details and information about the work they do. These calls are bogus.

Any person who receives a call of this nature should ask for a name and contact number, or dial 1471 to ascertain the caller’s telephone number, and then contact Emma Kerby-Evans at The Journal on 020 7572 2414

Jobs and Classified advertising



Leading Articles   294

PJ   2008;280:294
PDF (30K)


Confidence undermined 294
After heralding the new pharmacy contract introduced nearly three years ago as the lever to develop a clinically focused community pharmacy sector, the Pharmaceutical Services Negotiating Committee seems to be developing a new message over its funding
PJ   2008;280:294
Full Text

No black or white answers 294
With the number of tests being carried out in the NHS annually running into the hundreds of millions and with the recent massive expansion in tests available for the public to buy, concern was raised earlier this week about the lack of regulation of all these different products
PJ   2008;280:294
Full Text

Top

News & Features   295-302

News summary  295-301
PJ   2008;280:295-301
Headlines   PDF (210K)

Lead stories
-PSNC chairman: pharmacy's confidence is shaken
-Lansley tells of Category M “boom and bust”
-Oral contraception PGD starts in Manchester
-Banksy artwork appears on London pharmacy wall
-Revised Society election details
-Budget
-Prescription charge rises by 25p to £7.10 in England
-Law change to force companies to report all ADRs
-Health tests need to be evaluated
-SMC approves infliximab for child Crohn's disease
-Novel vaccine reduces BP by targeting angiotensin II
-Study supports use of aromatase inhibitors after tamoxifen use ends

MHRA gives industry a morality check 302
Legislative changes will force pharmaceutical companies to report promptly the side effects of all medicines after an attempt by the Medicines and Healthcare products Regulatory Agency to prosecute GlaxoSmithKline for allegedly withholding safety data on Seroxat failed. Dawn Connelly reports
PJ   2008;280:302
Full Text   PDF (40K)

Top

Products   303

PJ   2008;280:303
PDF (40K)

Products   303
-SPC changes
-Prescription products
-Supply issues
PJ   2008;280:303
Full Text

Announcements   303
-DermaSilk
-UCB Pharma distribution
PJ   2008;280:303
Full Text

Medical device alert   303
-Smiths Medical cassette reservoirs for CADD pumps
PJ   2008;280:303
Full Text

Top

Broad Spectrum   304

Why we need industrial pharmacists 304
By Stephen Goundrey-Smith
PJ   2008;280:304
Full Text   PDF (30K)

Top

Letters   305-308

-Category M medicines
-Community pharmacy
-Primary care contracts
-100-hour pharmacies
-PCT commissioning
-Prescription charges
-Medicines use reviews
-Dispensing
-Minor ailment scheme
-Adverse drug reactions
-Asthma management
-Non-practising status
-The Society
PJ   2008;280:305-308
Full Text   PDF (60K)

Top

Articles   309-318

Landmark drugs
Zidovudine — a harbinger of hope for sufferers from AIDS in the 1980s 309-310
In this sixth article in a series on landmark drugs, Jenny Bryan looks at the antiviral zidovudine, which, as the first drug to be licensed for the treatment of AIDS, brought hope to sufferers, who at the time were mainly gay men, and saved them from an automatic death sentence
PJ   2008;280:309-310
Full Text   PDF (60K)


Headache resources
Guidelines for community pharmacists on the management of headache 311-318
Headache is a significant public health problem that is often suitable for pharmacists to manage because patients turn to them for help or to self-medicate, rather than visit their GP. Christine Glover and colleagues outline their evidence-based guidelines for pharmacists
PJ   2008;280:311-318
Summary   PDF (100K)

Top

Footler   319

PJ   2008;280:319
PDF (50K)


MoonbathingBy the light of the silvery moon … 319
Exposure to too much sunlight is unhealthy for us, we are told. We know there are links between sunshine holidays, sunbeds and skin cancer. Conversely we have recently been informed that too little time spent in the sun is also bad for us. Anyone living north of Birmingham in our dark winter days is unlikely to be producing enough vitamin D. Taking a vitamin supplement has been recommended to prevent rickets, which we had hoped was a problem of the past for children
PJ   2008;280:319
Full Text

Leave those freckles alone 319
A discussion broke out recently as to whether freckles are an attractive part of one’s features or something to get rid of
PJ   2008;280:319
Full Text

How biowalls improve well-being 319
We are gradually understanding the need to improve our environment. Wind turbines, like them or not, are multiplying, and solar panels with their big brothers, solar walls and solar roofs are helping to produce “green” energy. Green roofs covered with closely packed plants growing in a few inches of soil on a waterproof layer in place of roof tiles help to insulate buildings, collect rainwater and reduce air pollution
PJ   2008;280:319
Full Text

Top
The Society    320-321

Also in this section

Official notices
Obituaries & tributes
Branch/Society meetings

PJ   2008;280:320-321
PDF (200K)


Official notices 2001 to present

Health Committee 320
PJ   2008;280:320
Full Text  

Disciplinary Committee 320
PJ   2008;280:320
Full Text  


Obituaries & tributes 321

Obituaries
-Grainger
-Huntley
-Kitchener
-MacDonald

Tribute
-Huntley


PJ   2008;280:321
Full Text

Top

My career   322

Careers

From HIV to haemato-oncologyA move from HIV to haemato-oncology 322
This article looks at how working as an HIV specialist prepared Elizabeth Davies for a haemato-oncology post
PJ   2008;280:322
Full Text   PDF (50K)

Top

Diary
Diary / Health events

Branch meetings 321
PJ   2008;280:321
Full Text

Society meetings 321
-Biologically active compounds in foods and drinks (1 May)
PJ   2008;280:321
Full Text

Future events 303
-Gene and immunotherapy (19 March)
-CPPE learning@lunch (April/May)
PJ   2008;280:303
Full Text  

Resources 303
-NHS operating framework
PJ   2008;280:303
Full Text

Top

©The Pharmaceutical Journal